Literature DB >> 32540234

Acceptability and Validity of the EQ-5D in Patients Living With Dementia.

Bernhard Michalowsky1, Feng Xie2, Thomas Kohlmann3, Johannes Gräske4, Markus Wübbeler5, Jochen René Thyrian6, Wolfgang Hoffmann7.   

Abstract

OBJECTIVES: To assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer's Diseases (QoL-AD) in patients living with dementia.
METHODS: The analysis was based on 560 dyads of persons with dementia and their caregivers of the multicenter observational study of dementia care networks in Germany (DemNet-D). Health-related quality of life was assessed by face-to-face interviews using the EQ-5D-3L (self-rating) and the QoL-AD (self- and proxy-rating). The number of missing values, the score ranges (observed vs possible range) and the floor and ceiling effects were used to assess the acceptability. We used one-way analyses of variance and multivariate linear regression models to evaluate the discriminative ability. The convergent validity was assessed using Spearman's correlation coefficient (rs) and multivariate regression models.
RESULTS: The EQ-5D index had a higher response rate (89% vs 84%) and a comparable floor (>1%) but a higher ceiling effect (18% vs >1%) compared with the QoL-AD. Both measures can significantly differentiate between different stages of general health, instrumental activities of daily living, and depression. The EQ-5D index and the visual analog scale self-rating scores strongly correlated with the QoL-AD self-rating (rs = 0.644 and 0.553, respectively) but not with the proxy-rating score (rs = 0.314 and rs = 0.170, respectively), which was confirmed by multivariate regression analyses.
CONCLUSION: The results satisfy acceptability, discriminative ability, and convergent validity for moderately cognitively and functionally impaired patients living with dementia. The EQ-5D-3L performed comparably with the QoL-AD, and could, therefore, be used in economic evaluations in dementia. The differences between self- and proxy-ratings should be evaluated and considered in the interpretation of health-related quality of life scores.
Copyright © 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; EQ-5D; dementia; patient-reported outcomes; preference-based measures; quality of life; validation

Mesh:

Year:  2020        PMID: 32540234     DOI: 10.1016/j.jval.2020.01.022

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  8 in total

1.  Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia.

Authors:  Richard Huan Xu; Dong Dong; Nan Luo; Eliza Lai-Yi Wong; Yushan Wu; Siyue Yu; Renchi Yang; Junshuai Liu; Huiqin Yuan; Shuyang Zhang
Journal:  Eur J Health Econ       Date:  2021-03-24

Review 2.  Measurement properties of the EQ-5D in populations with a mean age of ≥ 75 years: a systematic review.

Authors:  Sophie Gottschalk; Hans-Helmut König; Mona Nejad; Judith Dams
Journal:  Qual Life Res       Date:  2022-08-01       Impact factor: 3.440

3.  Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age.

Authors:  Ole Marten; Wolfgang Greiner
Journal:  Health Econ Rev       Date:  2022-05-20

Review 4.  The Humanistic and Economic Burden of Alzheimer's Disease.

Authors:  Amir Abbas Tahami Monfared; Michael J Byrnes; Leigh Ann White; Quanwu Zhang
Journal:  Neurol Ther       Date:  2022-02-22

5.  A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in Germany.

Authors:  Tara Peseschkian; Isabell Cordts; René Günther; Benjamin Stolte; Daniel Zeller; Carsten Schröter; Ute Weyen; Martin Regensburger; Joachim Wolf; Ilka Schneider; Andreas Hermann; Moritz Metelmann; Zacharias Kohl; Ralf A Linker; Jan Christoph Koch; Boriana Büchner; Ulrike Weiland; Erik Schönfelder; Felix Heinrich; Alma Osmanovic; Thomas Klopstock; Johannes Dorst; Albert C Ludolph; Matthias Boentert; Tim Hagenacker; Marcus Deschauer; Paul Lingor; Susanne Petri; Olivia Schreiber-Katz
Journal:  Brain Sci       Date:  2021-03-14

Review 6.  Feasibility of the EQ-5D in the elderly population: a systematic review of the literature.

Authors:  Ole Marten; Laura Brand; Wolfgang Greiner
Journal:  Qual Life Res       Date:  2021-10-06       Impact factor: 3.440

Review 7.  Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review.

Authors:  Anju D Keetharuth; Hannah Hussain; Donna Rowen; Allan Wailoo
Journal:  Health Qual Life Outcomes       Date:  2022-09-28       Impact factor: 3.077

8.  Feasibility and validity of the EQ-5D-3L in the elderly Europeans: a secondary data analysis using SHARE(d) data.

Authors:  Ines Buchholz; Ole Marten; Mathieu F Janssen
Journal:  Qual Life Res       Date:  2022-05-27       Impact factor: 3.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.